{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T02:40:22Z","timestamp":1739846422441,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"DOI":"10.1186\/s13104-025-07134-1","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T02:06:26Z","timestamp":1739844386000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Accuracy of anti-mycobacterial protein 51 antibodies as a biomarker for latent TB infection in asymptomatic HIV positive individuals: a cross-sectional diagnostic study"],"prefix":"10.1186","volume":"18","author":[{"given":"Josephine Victo","family":"Namugga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Musubika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Niwagaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Mayito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Obondo James","family":"Sande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,17]]},"reference":[{"key":"7134_CR1","unstructured":"World Health Organisation. 2022. Available from: www.paho.org\/en\/campaigns\/world-tuberculosis-day-2022"},{"key":"7134_CR2","unstructured":"UNAIDS W. 2022 [cited 2022 May 15]. Available from: www.unaids.org\/en\/resources\/documents\/2022\/tb-fact-sheet"},{"key":"7134_CR3","unstructured":"WHO. Tuberculosis [Internet]. 2021 [cited 2022 Jul 16]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/tuberculosis"},{"key":"7134_CR4","unstructured":"WHO. Facts sheet. 2021."},{"key":"7134_CR5","doi-asserted-by":"crossref","unstructured":"Houben RMGJ, Dodd PJ. The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling. Metcalfe JZ, editor. PLOS Med. 2016;13(10):e1002152.","DOI":"10.1371\/journal.pmed.1002152"},{"key":"7134_CR6","unstructured":"Centers for Disease Control and Prevention. TB and HIV coinfection [Internet]. 2016. Available from: https:\/\/www.cdc.gov\/tb\/topic\/basics\/tbhivcoinfection.htm"},{"key":"7134_CR7","unstructured":"NIH gov. HIV and Opportunistic Infections, Coinfections, and Conditions [Internet]. 2021. Available from: https:\/\/hivinfo.nih.gov\/understanding-hiv\/fact-sheets\/hiv-and-tuberculosis-tb"},{"issue":"4","key":"7134_CR8","doi-asserted-by":"publisher","first-page":"e00021","DOI":"10.1128\/CMR.00021-18","volume":"31","author":"PK Drain","year":"2018","unstructured":"Drain PK, Bajema KL, Dowdy D, Dheda K, Naidoo K, Schumacher SG, et al. Incipient and subclinical tuberculosis: a clinical review of early stages and progression of infection. Clin Microbiol Rev. 2018;31(4):e00021\u201318.","journal-title":"Clin Microbiol Rev"},{"key":"7134_CR9","unstructured":"Technology Research Education and Technical Assistance for Tuberculosis. Uganda TREAT TB [Internet]. [cited 2022 Jul 16]. Available from: https:\/\/treattb.org\/trial-sites\/uganda\/"},{"key":"7134_CR10","doi-asserted-by":"publisher","unstructured":"Heifets LB, Good RC. Current Laboratory Methods for the Diagnosis of Tuberculosis. In: Bloom BR, editor. Tuberculosis [Internet]. Washington, DC, USA: ASM Press; 2014 [cited 2022 May 14]. pp. 85\u2013110. Available from: https:\/\/doi.org\/10.1128\/9781555818357.ch7","DOI":"10.1128\/9781555818357.ch7"},{"key":"7134_CR11","first-page":"33","volume":"4","author":"AJ Caulfield","year":"2016","unstructured":"Caulfield AJ, Wengenack NL. Diagnosis of active tuberculosis disease: from microscopy to molecular techniques. J Clin Tuberc Mycobact Dis. 2016;4:33\u201343.","journal-title":"J Clin Tuberc Mycobact Dis"},{"issue":"12","key":"7134_CR12","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nrmicro2236","volume":"7","author":"CE Barry","year":"2009","unstructured":"Barry CE, Boshoff HI, Dartois V, Dick T, Ehrt S, Flynn J, et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol. 2009;7(12):845\u201355.","journal-title":"Nat Rev Microbiol"},{"issue":"suppl 4","key":"7134_CR13","doi-asserted-by":"publisher","first-page":"S1179","DOI":"10.1093\/infdis\/jir451","volume":"204","author":"JM Achkar","year":"2011","unstructured":"Achkar JM, Jenny-Avital ER. Incipient and subclinical tuberculosis: defining early Disease States in the context of host Immune Response. J Infect Dis. 2011;204(suppl 4):S1179\u201386.","journal-title":"J Infect Dis"},{"issue":"5","key":"7134_CR14","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.eimc.2017.11.014","volume":"36","author":"J Dom\u00ednguez","year":"2018","unstructured":"Dom\u00ednguez J, Latorre I, Santin M. Diagnosis and therapeutic approach of latent tuberculosis infection. Enfermedades Infecc Microbiol Clin Engl Ed. 2018;36(5):302\u201311.","journal-title":"Enfermedades Infecc Microbiol Clin Engl Ed"},{"issue":"1","key":"7134_CR15","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.pulmoe.2021.07.003","volume":"28","author":"K Fukushima","year":"2022","unstructured":"Fukushima K, Akagi K, Kondo A, Kubo T, Sakamoto N, Mukae H. First clinical evaluation of the QIAreachTM QuantiFERON-TB for Tuberculosis infection and active pulmonary disease. Pulmonology. 2022;28(1):6\u201312.","journal-title":"Pulmonology"},{"key":"7134_CR16","doi-asserted-by":"crossref","unstructured":"Biraro IA, Kimuda S, Egesa M, Cose S, Webb EL, Joloba M et al. The Use of Interferon Gamma Inducible Protein 10 as a Potential Biomarker in the Diagnosis of Latent Tuberculosis Infection in Uganda. Delogu G, editor. PLOS ONE. 2016;11(1):e0146098.","DOI":"10.1371\/journal.pone.0146098"},{"key":"7134_CR17","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.3389\/fimmu.2020.02006","volume":"11","author":"C Carranza","year":"2020","unstructured":"Carranza C, Pedraza-Sanchez S, de Oyarzabal-Mendez E, Torres M. Diagnosis for latent tuberculosis infection: New Alternatives. Front Immunol. 2020;11:2006.","journal-title":"Front Immunol"},{"issue":"2","key":"7134_CR18","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1128\/CDLI.12.2.354-358.2005","volume":"12","author":"KK Singh","year":"2005","unstructured":"Singh KK, Dong Y, Belisle JT, Harder J, Arora VK, Laal S. Antigens of Mycobacterium tuberculosis recognized by antibodies during Incipient, subclinical tuberculosis. Clin Vaccine Immunol. 2005;12(2):354\u20138.","journal-title":"Clin Vaccine Immunol"},{"key":"7134_CR19","doi-asserted-by":"crossref","unstructured":"Wanchu A, Dong Y, Sethi S, Myneedu VP, Nadas A, Liu Z, Biomarkers for Clinical and Incipient Tuberculosis: Performance in a TB-Endemic Country. Gold JA,PLoS ONE., Corbett EL, Charalambous S, Moloi VM, Fielding K, Grant AD, Dye C, De Cock KM, Hayes RJ, Williams BG, Churchyard GJ et al. 2004. Human immunodeficiency virus and the prevalence of undiagnosed tuberculosis in African gold miners. Am. J. Resp. Crit. Care Med. 170:673\u2013679.","DOI":"10.1164\/rccm.200405-590OC"},{"issue":"3","key":"7134_CR20","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1128\/CVI.00503-09","volume":"17","author":"JM Achkar","year":"2010","unstructured":"Achkar JM, Jenny-Avital E, Yu X, Burger S, Leibert E, Bilder PW, et al. Antibodies against Immunodominant Antigens of Mycobacterium tuberculosis in subjects with suspected tuberculosis in the United States compared by HIV Status. Clin Vaccine Immunol. 2010;17(3):384\u201392.","journal-title":"Clin Vaccine Immunol"},{"issue":"11","key":"7134_CR21","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1128\/CVI.00158-06","volume":"13","author":"JM Achkar","year":"2006","unstructured":"Achkar JM, Dong Y, Holzman RS, Belisle J, Kourbeti IS, Sherpa T, et al. Mycobacterium tuberculosis Msynthasenthase- and MPT51-Based Serodiagnostic Assay as an Adjunct to Rapid Identification of Pulmonary Tuberculosis. Clin Vaccine Immunol. 2006;13(11):1291\u20133.","journal-title":"Clin Vaccine Immunol"},{"key":"7134_CR22","unstructured":"WHO. The End TB strategy [Internet]. 2015 [cited 2022 Jul 16]. Available from: https:\/\/www.google.com\/url?sa=t%26rct=j%26q=%26esrc=s%26source=web%26cd=%26ved=2ahUKEwi05qry6_v4AhVKyKQKHfXDCksQFnoECBEQAQ%26url=https%3A%2F%2Fapps.who.int%2Firis%2Fbitstream%2Fhandle%2F10665%2F259636%2FTBstrat-eng.pdf%3Fsequence%3D1%26usg=AOvVaw01JU6kPJKcXw9yNaqiaqoT"},{"issue":"4","key":"7134_CR23","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1080\/00365540310000292","volume":"35","author":"B Ramalingam","year":"2003","unstructured":"Ramalingam B, Devi KRU, Raja A. Isotype-specific Anti-38 and 27\u00a0kDa (mpt 51) response in Pulmonary Tuberculosis with Human Immunodeficiency Virus Coinfection. Scand J Infect Dis. 2003;35(4):234\u20139.","journal-title":"Scand J Infect Dis"},{"issue":"4","key":"7134_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0002071","volume":"3","author":"A Wanchu","year":"2008","unstructured":"Wanchu A, Dong Y, Sethi S, Myneedu VP, Nadas A, Liu Z, et al. Biomarkers for clinical and incipient tuberculosis: performance in a TB-endemic country. PLoS ONE. 2008;3(4):1\u20138.","journal-title":"PLoS ONE"},{"issue":"9","key":"7134_CR25","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/j.1553-2712.1996.tb03538.x","volume":"3","author":"NMF Buderer","year":"1996","unstructured":"Buderer NMF. Statistical methodology: I. incorporating the prevalence of Disease into the sample size calculation for sensitivity and specificity. Acad Emerg Med. 1996;3(9):895\u2013900.","journal-title":"Acad Emerg Med"},{"issue":"4","key":"7134_CR26","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/j.1365-2958.2006.05151.x","volume":"60","author":"AG Kinhikar","year":"2006","unstructured":"Kinhikar AG, Vargas D, Li H, Mahaffey SB, Hinds L, Belisle JT, et al. Mycobacterium tuberculosis malate synthase is a laminin-binding adhesin. Mol Microbiol. 2006;60(4):999\u20131013.","journal-title":"Mol Microbiol"},{"issue":"2","key":"7134_CR27","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jmb.2003.11.001","volume":"335","author":"RA Wilson","year":"2004","unstructured":"Wilson RA, Maughan WN, Kremer L, Besra GS, F\u00fctterer K. The structure of Mycobacterium tuberculosis MPT51 (FbpC1) defines a New Family of non-catalytic \u03b1\/\u03b2 hydrolases. J Mol Biol. 2004;335(2):519\u201330.","journal-title":"J Mol Biol"},{"issue":"10","key":"7134_CR28","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.1099\/mic.0.030858-0","volume":"155","author":"MF Dunn","year":"2009","unstructured":"Dunn MF, Ram\u00edrez-Trujillo JA, Hern\u00e1ndez-Lucas I. Major roles of isocitrate lyase and malate synthase in bacterial and fungal pathogenesis. Microbiology. 2009;155(10):3166\u201375.","journal-title":"Microbiology"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-025-07134-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-025-07134-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-025-07134-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T02:06:35Z","timestamp":1739844395000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-025-07134-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,17]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7134"],"URL":"https:\/\/doi.org\/10.1186\/s13104-025-07134-1","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,17]]},"assertion":[{"value":"15 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in compliance with the Declaration of Helsinki and Good Clinical Practice Guidelines. Ethical approval was obtained from the School of Biomedical Sciences Research Ethics Committee (Approval number: SBS-2022-265) under the College of Health Sciences at Makerere University and the IDI REC. Administrative clearance was obtained from the IDI management for conducting the research at the IDI adult HIV clinic. Informed written consent was obtained from all study participants before any study procedure, and their information was treated with confidentiality.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"73"}}